Kilotest: Diagnoses of content beyond landmarks violation by HTML element 843 on Society for Evidence Based Gender Medicine (SEGM) page

Basics

About the page

• URL: https://segm.org/
• Tested 3 days ago on 2026-10-07 at 22:28 by job 261007T2202-905
• Summary of results:
  • Rule engines:
    • Called: 12
    • Were able to test: 12
    • Reported any rule violations: 12
  • Violations: 3251
  • Violators: 625
  • Issues: 57
• Download the full technical report (JSON)

About the issue

• Why it matters: User cannot get help on how some of the page is organized
• Priority: lowest
• Related WCAG standard: 1.3.6
• Reported by 4 rule engines (Accessibility Checker + Alfa + Axe + Pour)
• Violations: 776
• Violators: 430

About the violator

• Tag name: LI
• Text: England banned the use of puberty blockers for gender dysphoria outside of research trials. NHS England's interim clinical policy states that “The primary intervention for children and young people who are assessed as suitable for The Service is psychosocial (including) and psychological support and intervention; the psychoeducation main objective is to alleviate distress associated with gender incongruence and promote the individual’s global functioning and wellbeing.” On March 21, 2024, the NHS also updated its policy on cross-sex hormones for youth, removing the requirement of puberty blockers as a prerequisite step for cross-sex hormone treatment, presumably to make two policies better aligned (since puberty blockers will no longer be available). The final Cass Report was published in April 2024. SEGM's analysis concluded that the report signaled the end of the era of "gender-affirmative," gender-clinic-led model of care in England, with significant worldwide implications. No new prescriptions of cross-sex hormones for minors have been issued since the publication of the final Cass Report, and the use of puberty blockers are only be allowed as part of the PATHWAYS clinical trial, which is set to start recruitment during 2026.
• Start tag: <li>
• XPath: /html/body/div[1]/section[8]/div[1]/div[1]/div[1]/div[1]/div[1]/div[1]/ul[1]/li[3]
• Bounding box: x = 152, y = 7916, width = 1656, height = 126
• Reported by Alfa + Pour

Take me there

Diagnoses

Here is how rule engines diagnose the content beyond landmarks issue for HTML element 843 of the Society for Evidence Based Gender Medicine (SEGM) page.

1. The text is not included in a landmark region

   Rule engine: Alfa (Siteimprove)

   Rule: r57

2. The text is not included in a landmark region

   Rule engine: Alfa (Siteimprove)

   Rule: r57

3. The text is not included in a landmark region

   Rule engine: Alfa (Siteimprove)

   Rule: r57

4. The text is not included in a landmark region

   Rule engine: Alfa (Siteimprove)

   Rule: r57

5. The text is not included in a landmark region

   Rule engine: Alfa (Siteimprove)

   Rule: r57

6. The text is not included in a landmark region

   Rule engine: Alfa (Siteimprove)

   Rule: r57

7. The text is not included in a landmark region

   Rule engine: Alfa (Siteimprove)

   Rule: r57

8. The text is not included in a landmark region

   Rule engine: Alfa (Siteimprove)

   Rule: r57

9. All readable content belongs inside a landmark region

   Rule engine: Pour (David Yarham and Geoffrey Crofte)

   Rule: region